Summit Pharmaceuticals International Corporation (Corporate ID: 9010001103866) is a mid-sized company operating in the 製造業 sector headquartered in 東京都千代田区一ツ橋1丁目2番2号. Led by 代表取締役 奥山勝. Latest operational metrics report workforce: 180 employees, capital: ¥480 JPY. Fully registered under Japan's National Tax Agency Qualified Invoice System (Invoice No: T9010001103866). Official contact (03-5220-1500), corporate governance, and multi-year financial statements are openly accessible on Kigyou-list.
Official change history records regarding corporate name, registered address, and legal entity designations synced with Japan National Tax Agency (国税庁).
Head office relocated to [New] "東京都千代田区一ツ橋1丁目2番2号" from [Old] "東京都中央区晴海1丁目8番12号".
13-digit Corporate Number "9010001103866" was officially assigned by the National Tax Agency Commissioner with corporate name "住商ファーマインターナショナル株式会社".
Cross-check reviews, press releases, and compliance background across top Japanese portals.
The official representative phone number for Summit Pharmaceuticals International Corporation is 03-5220-1500 (FAX: 03-5220-1501). Head office is located at 東京都千代田区一ツ橋1丁目2番2号. Verified contact channels and executive directories are accessible on Kigyou-list.
Summit Pharmaceuticals International Corporation's official 13-digit National Tax Agency Corporate Number is 9010001103866. It is officially registered as a Qualified Invoice Issuer under Japan's consumption tax invoice system with registration ID T9010001103866.
Summit Pharmaceuticals International Corporation is officially registered and headquartered at Postal Code 1000003, 東京都千代田区一ツ橋1丁目2番2号. Complete regional jurisdiction and legal relocation history are verified via Japan's National Tax Agency.
Outreach to Summit Pharmaceuticals International Corporation or acquire targeted lookalike company datasets.
Summit Pharmaceuticals International Corporationに関連する公的異動登記および東京都の各カテゴリ別データベースへの直通インデックスです。 最新の法人登記データや採用活動の動向を各ハブにて毎日自動更新しています。
※ Corporate information on this profile is aggregated, verified, and structured based on official open data provided by the National Tax Agency (国税庁) and METI gBizINFO.
Summit Pharmaceuticals International Corporation currently employs 180 personnel. Most recently reported annual revenue stands at undisclosed.
The official representative of Summit Pharmaceuticals International Corporation is 代表取締役 奥山勝, with a registered capital of ¥480 JPY. It is privately held.
On Kigyou-list, users can review verified financial metrics, legal registry history, corporate signals (hiring, subsidies, trademarks), and export standardized CSV datasets for B2B intelligence.